The Evolution of the Stem Cell Theory for Heart Failure

EBioMedicine

Volumn 2, Issue 12, 2015, Pages 1871-1879

  Silvestre, Jean Sébastien ^a   Menasché, Philippe ^a,b  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Cardiac regeneration; Heart failure; Inflammation; Myocardial infarction; Stem cells

Indexed keywords

CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL REGENERATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; IMMUNOMODULATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOKING; STEM CELL TRANSPLANTATION; ANIMAL; BIOLOGICAL THERAPY; CYTOLOGY; PHYSIOLOGY; REGENERATION; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; HEART FAILURE; HUMANS; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84958836436     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.11.010     Document Type: Review

References (93)

1. Aurora A.B., Porrello E.R., Tan W., Mahmoud A.I., Hill J.A., Bassel-Duby R., Sadek H.A., Olson E.N. Macrophages are required for neonatal heart regeneration. J. Clin. Invest. 2014, 124:1382-1392.
2. Ayala-Lugo A., Tavares A.M., Paz A.H., Alegretti A., Miquelito L., Bock H., Giugliani R., Clausell N., Cirne-Lima E., Rohde L.E. Age-dependent availability and functionality of bone marrow stem cells in an experimental model of acute and chronic myocardial infarction. Cell Transplant. 2011, 20:407-419.
3. Barile L., Lionetti V., Cervio E., Matteucci M., Gherghiceanu M., Popescu L.M., Torre T., Siclari F., Moccetti T., Vassalli G. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc. Res. 2014, 103:530-541.
4. Bartunek J., Behfar A., Dolatabadi D., Vanderheyden M., Ostojic M., Dens J., El Nakadi B., Banovic M., Beleslin B., Vrolix M., Legrand V., Vrints C., Vanoverschelde J.L., Crespo-Diaz R., Homsy C., Tendera M., Waldman S., Wijns W., Terzic A. Cardiopoietic stem cell therapy in heart failure: the C-CURE (cardiopoietic stem cell therapy in heart failure) multicenter randomized trial with lineage-specified biologics. J. Am. Coll. Cardiol. 2013, 61:2329-2338.
5. Bauer N., Wilsch-Brauninger M., Karbanova J., Fonseca A.V., Strauss D., Freund D., Thiele C., Huttner W.B., Bornhauser M., Corbeil D. Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles-a role of the endocytic-exocytic pathway. EMBO Mol. Med. 2011, 3:398-409.
6. Behfar A., Crespo-Diaz R., Terzic A., Gersh B.J. Cell therapy for cardiac repair-lessons from clinical trials. Nat. Rev. Cardiol. 2014, 11:232-246.
7. Bellamy V., Vanneaux V., Bel A., Nemetalla H., Emmanuelle Boitard S., Farouz Y., Joanne P., Perier M.C., Robidel E., Mandet C., Hagege A., Bruneval P., Larghero J., Agbulut O., Menasche P. Long-term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold. J. Heart Lung Transplant. 2015, 34:1198-1207.
8. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabe-Heider F., Walsh S., Zupicich J., Alkass K., Buchholz B.A., Druid H., Jovinge S., Frisen J. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
9. Bergmann O., Zdunek S., Felker A., Salehpour M., Alkass K., Bernard S., Sjostrom S.L., Szewczykowska M., Jackowska T., Dos Remedios C., Malm T., Andra M., Jashari R., Nyengaard J.R., Possnert G., Jovinge S., Druid H., Frisen J. Dynamics of cell generation and turnover in the human heart. Cell 2015, 161:1566-1575.
10. Bobis-Wozowicz S., Kmiotek K., Sekula M., Kedracka-Krok S., Kamycka E., Adamiak M., Jankowska U., Madetko-Talowska A., Sarna M., Bik-Multanowski M., Kolcz J., Boruczkowski D., Madeja Z., Dawn B., Zuba-Surma E.K. Human induced pluripotent stem cell-derived microvesicles transmit RNAs and proteins to recipient mature heart cells modulating cell fate and behavior. Stem Cells 2015, 33:2748-2761.
11. Bolli R., Tang X.L., Sanganalmath S.K., Rimoldi O., Mosna F., Abdel-Latif A., Jneid H., Rota M., Leri A., Kajstura J. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 2013, 128:122-131.
12. Burchfield J.S., Iwasaki M., Koyanagi M., Urbich C., Rosenthal N., Zeiher A.M., Dimmeler S. Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ. Res. 2008, 103:203-211.
13. Burt R.K., Chen Y.H., Verda L., Lucena C., Navale S., Johnson J., Han X., Lomasney J., Baker J.M., Ngai K.L., Kino A., Carr J., Kajstura J., Anversa P. Mitotically inactivated embryonic stem cells can be used as an in vivo feeder layer to nurse damaged myocardium after acute myocardial infarction: a preclinical study. Circ. Res. 2012, 111:1286-1296.
14. Cheng K., Malliaras K., Smith R.R., Shen D., Sun B., Blusztajn A., Xie Y., Ibrahim A., Aminzadeh M.A., Liu W., Li T.S., De Robertis M.A., Marban L., Czer L.S., Trento A., Marban E. Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair. JACC Heart. Fail. 2014, 2:49-61.
15. Chong J.J., Yang X., Don C.W., Minami E., Liu Y.W., Weyers J.J., Mahoney W.M., Van Biber B., Cook S.M., Palpant N.J., Gantz J.A., Fugate J.A., Muskheli V., Gough G.M., Vogel K.W., Astley C.A., Hotchkiss C.E., Baldessari A., Pabon L., Reinecke H., Gill E.A., Nelson V., Kiem H.P., Laflamme M.A., Murry C.E. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014, 510:273-277.
16. Chugh A.R., Beache G.M., Loughran J.H., Mewton N., Elmore J.B., Kajstura J., Pappas P., Tatooles A., Stoddard M.F., Lima J.A., Slaughter M.S., Anversa P., Bolli R. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 2012, 126:S54-S64.
17. Citro L., Naidu S., Hassan F., Kuppusamy M.L., Kuppusamy P., Angelos M.G., Khan M. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction. PLoS One 2014, 9.
18. De Couto G., Liu W., Tseliou E., Sun B., Makkar N., Kanazawa H., Arditi M., Marban E. Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. J. Clin. Invest. 2015, 125:3147-3162.
19. Den Haan M.C., Grauss R.W., Smits A.M., Winter E.M., Van Tuyn J., Pijnappels D.A., Steendijk P., Gittenberger-DE GROOT A.C., VAN DER LAARSE A., Fibbe W.E., DE VRIES A.A., Schalij M.J., Doevendans P.A., Goumans M.J., Atsma D.E. Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts. J. Cell. Mol. Med. 2012, 16:1508-1521.
20. Desai A.S., Mcmurray J.J., Packer M., Swedberg K., Rouleau J.L., Chen F., Gong J., Rizkala A.R., Brahimi A., Claggett B., Finn P.V., Hartley L.H., Liu J., Lefkowitz M., Shi V., Zile M.R., Solomon S.D. Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. Eur. Heart J. 2015, 36:1990-1997.
21. Ebrahimian T.G., Heymes C., You D., Blanc-Brude O., Mees B., Waeckel L., Duriez M., Vilar J., Brandes R.P., Levy B.I., Shah A.M., Silvestre J.S. NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol 2006, 169:719-728.
22. Ellison G.M., Vicinanza C., Smith A.J., Aquila I., Leone A., Waring C.D., Henning B.J., Stirparo G.G., Papait R., Scarfo M., Agosti V., Viglietto G., Condorelli G., Indolfi C., Ottolenghi S., Torella D., Nadal-Ginard B. Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 2013, 154:827-842.
23. Epelman S., Lavine K.J., Beaudin A.E., Sojka D.K., Carrero J.A., Calderon B., Brija T., Gautier E.L., Ivanov S., Satpathy A.T., Schilling J.D., Schwendener R., Sergin I., Razani B., Forsberg E.C., Yokoyama W.M., Unanue E.R., Colonna M., Randolph G.J., Mann D.L. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 2014, 40:91-104.
24. Epelman S., Lavine K.J., Randolph G.J. Origin and functions of tissue macrophages. Immunity 2014, 41:21-35.
25. Fisher S.A., Doree C., Mathur A., Martin-Rendon E. Meta-analysis of cell therapy trials for patients with heart failure. Circ. Res. 2015, 116:1361-1377.
26. Garbern J.C., Lee R.T. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell 2013, 12:689-698.
27. Gerbin K.A., Yang X., Murry C.E., Coulombe K.L. Enhanced electrical integration of engineered human myocardium via intramyocardial versus epicardial delivery in infarcted rat hearts. PLoS One 2015, 10.
28. Gilbert R.E., Krum H. Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy. Lancet 2015, 385:2107-2117.
29. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., MU H., Noiseux N., Zhang L., Pratt R.E., Ingwall J.S., Dzau V.J. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 2005, 11:367-368.
30. Govaert J.A., Swijnenburg R.J., Schrepfer S., Xie X., Van Der Bogt K.E., Hoyt G., Stein W., Ransohoff K.J., Robbins R.C., Wu J.C. Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium. J. Heart Lung Transplant. 2009, 28(1158-1165).
31. Gray W.D., French K.M., Ghosh-Choudhary S., Maxwell J.T., Brown M.E., Platt M.O., Searles C.D., Davis M.E. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ. Res. 2015, 116:255-263.
32. Gyongyosi M., Wojakowski W., Lemarchand P., Lunde K., Tendera M., Bartunek J., Marban E., Assmus B., Henry T.D., Traverse J.H., Moye L.A., Surder D., Corti R., Huikuri H., Miettinen J., Wohrle J., Obradovic S., Roncalli J., Malliaras K., Pokushalov E., Romanov A., Kastrup J., Bergmann M.W., Atsma D.E., Diederichsen A., Edes I., Benedek I., Benedek T., Pejkov H., Nyolczas N., Pavo N., Bergler-Klein J., Pavo I.J., Sylven C., Berti S., Navarese E.P., Maurer G., Investigators A. Meta-analysis of cell-based cardiac studies (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ. Res. 2015, 116:1346-1360.
33. Hare J.M., Fishman J.E., Gerstenblith G., Difede Velazquez D.L., Zambrano J.P., Suncion V.Y., Tracy M., Ghersin E., Johnston P.V., Brinker J.A., Breton E., Davis-sproul J., Schulman I.H., Byrnes J., Mendizabal A.M., Lowery M.H., Rouy D., Altman P., Wong Po Foo C., Ruiz P., Amador A., Da Silva J., Mcniece I.K., Heldman A.W., George R., Lardo A. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012, 308:2369-2379.
34. Hatzistergos K.E., Takeuchi L.M., Saur D., Seidler B., Dymecki S.M., Mai J.J., White I.A., Balkan W., Kanashiro-Takeuchi R.M., Schally A.V., Hare J.M. cKit+ Cardiac Progenitors of Neural Crest Origin 2015, Proc Natl Acad Sci U S A.
35. Haynesworth S.E., Baber M.A., Caplan A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J. Cell. Physiol. 1996, 166:585-592.
36. Heidt T., Courties G., Dutta P., Sager H.B., Sebas M., Iwamoto Y., Sun Y., Da Silva N., Panizzi P., Van Der Laan A.M., Swirski F.K., Weissleder R., Nahrendorf M. Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ. Res. 2014, 115:284-295.
37. Heldman A.W., Difede D.L., Fishman J.E., Zambrano J.P., Trachtenberg B.H., Karantalis V., Mushtaq M., Williams A.R., Suncion V.Y., Mcniece I.K., Ghersin E., Soto V., Lopera G., Miki R., Willens H., Hendel R., Mitrani R., Pattany P., Feigenbaum G., Oskouei B., Byrnes J., Lowery M.H., Sierra J., Pujol M.V., Delgado C., Gonzalez P.J., Rodriguez J.E., Bagno L.L., Rouy D., Altman P., Foo C.W., Da Silva J., Anderson E., Schwarz R., Mendizabal A., Hare J.M. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 2014, 311:62-73.
38. Hofmann U., Frantz S. Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction. Circ. Res. 2015, 116:354-367.
39. Houtgraaf J.H., Den Dekker W.K., Van Dalen B.M., Springeling T., De Jong R., Van Geuns R.J., Geleijnse M.L., Fernandez-Aviles F., Zijlsta F., Serruys P.W., Duckers H.J. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 2012, 59:539-540.
40. Iekushi K., Seeger F., Assmus B., Zeiher A.M., Dimmeler S. Regulation of cardiac microRNAs by bone marrow mononuclear cell therapy in myocardial infarction. Circulation 2012, 125(1765-73):S1-S7.
41. Jain R., LI D., Gupta M., Manderfield L.J., Ifkovits J.L., Wang Q., Liu F., Liu Y., Poleshko A., Padmanabhan A., Raum J.C., LI L., Morrisey E.E., LU M.M., Won K.J., Epstein J.A. HEART DEVELOPMENT. Integration of Bmp and Wnt signaling by Hopx specifies commitment of cardiomyoblasts. Science 2015, 348. (aaa6071).
42. Jesty S.A., Steffey M.A., Lee F.K., Breitbach M., Hesse M., Reining S., Lee J.C., Doran R.M., Nikitin A.Y., Fleischmann B.K., Kotlikoff M.I. c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:13380-13385.
43. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Tsutsumi Y., Ozono R., Masaki H., Mori Y., Iba O., Tateishi E., Kosaki A., Shintani S., Murohara T., Imaizumi T., Iwasaka T. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001, 104:1046-1052.
44. Khan M., Nickoloff E., Abramova T., Johnson J., Verma S.K., Krishnamurthy P., Mackie A.R., Vaughan E., Garikipati V.N., Benedict C., Ramirez V., Lambers E., Ito A., Gao E., Misener S., Luongo T., Elrod J., Qin G., Houser S.R., Koch W.J., Kishore R. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ. Res. 2015, 117:52-64.
45. Kinnaird T., Stabile E., Burnett M.S., Epstein S.E. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ. Res. 2004, 95:354-363.
46. Kinnaird T., Stabile E., Burnett M.S., Shou M., Lee C.W., Barr S., Fuchs S., Epstein S.E. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004, 109:1543-1549.
47. Korf-Klingebiel M., Kempf T., Sauer T., Brinkmann E., Fischer P., Meyer G.P., Ganser A., Drexler H., Wollert K.C. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur. Heart J. 2008, 29:2851-2858.
48. Lavine K.J., Epelman S., Uchida K., Weber K.J., Nichols C.G., Schilling J.D., Ornitz D.M., Randolph G.J., Mann D.L. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:16029-16034.
49. Lee C., Mitsialis S.A., Aslam M., Vitali S.H., Vergadi E., Konstantinou G., Sdrimas K., Fernandez-Gonzalez A., Kourembanas S. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 2012, 126:2601-2611.
50. Lee H.C., AN S.G., Lee H.W., Park J.S., Cha K.S., Hong T.J., Park J.H., Lee S.Y., Kim S.P., Kim Y.D., Chung S.W., Bae Y.C., Shin Y.B., Kim J.I., Jung J.S. Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study. Circ. J. 2012, 76:1750-1760.
51. Leroyer A.S., Ebrahimian T.G., Cochain C., Recalde A., Blanc-Brude O., Mees B., Vilar J., Tedgui A., Levy B.I., Chimini G., Boulanger C.M., Silvestre J.S. Microparticles from ischemic muscle promotes postnatal vasculogenesis. Circulation 2009, 119:2808-2817.
52. Levit R.D., Landazuri N., Phelps E.A., Brown M.E., Garcia A.J., Davis M.E., Joseph G., Long R., Safley S.A., Suever J.D., Lyle A.N., Weber C.J., Taylor W.R. Cellular encapsulation enhances cardiac repair. J Am Heart Assoc 2013, 2.
53. Li T.S., Cheng K., Malliaras K., Smith R.R., Zhang Y., Sun B., Matsushita N., Blusztajn A., Terrovitis J., Kusuoka H., Marban L., Marban E. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J. Am. Coll. Cardiol. 2012, 59:942-953.
54. Liu M.L., Nagai T., Tokunaga M., Iwanaga K., Matsuura K., Takahashi T., Kanda M., Kondo N., Naito A.T., Komuro I., Kobayashi Y. Anti-inflammatory peptides from cardiac progenitors ameliorate dysfunction after myocardial infarction. J Am Heart Assoc 2014, 3.
55. Loffredo F.S., Steinhauser M.L., Gannon J., Lee R.T. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 2011, 8:389-398.
56. Makkar R.R., Smith R.R., Cheng K., Malliaras K., Thomson L.E., Berman D., Czer L.S., Marban L., Mendizabal A., Johnston P.V., Russell S.D., Schuleri K.H., Lardo A.C., Gerstenblith G., Marban E. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012, 379:895-904.
57. Malliaras K., Ibrahim A., Tseliou E., Liu W., Sun B., Middleton R.C., Seinfeld J., Wang L., Sharifi B.G., Marban E. Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction. EMBO Mol Med 2014, 6:760-777.
58. Mathiasen A.B., Qayyum A.A., Jorgensen E., Helqvist S., Fischer-Nielsen A., Kofoed K.F., Haack-Sorensen M., Ekblond A., Kastrup J. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). Eur. Heart J. 2015, 36:1744-1753.
59. Menasche P., Alfieri O., Janssens S., Mckenna W., Reichenspurner H., Trinquart L., Vilquin J.T., Marolleau J.P., Seymour B., Larghero J., Lake S., Chatellier G., Solomon S., Desnos M., Hagege A.A. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189-1200.
60. Menasche P., Vanneaux V., Hagege A., Bel A., Cholley B., Cacciapuoti I., Parouchev A., Benhamouda N., Tachdjian G., Tosca L., Trouvin J.H., Fabreguettes J.R., Bellamy V., Guillemain R., Suberbielle Boissel C., Tartour E., Desnos M., Larghero J. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur. Heart J. 2015, 36:2011-2017.
61. Naftali-Shani N., Itzhaki-Alfia A., Landa-Rouben N., Kain D., Holbova R., Adutler-Lieber S., Molotski N., Asher E., Grupper A., Millet E., Tessone A., Winkler E., Kastrup J., Feinberg M.S., Zipori D., Pevsner-Fischer M., Raanani E., Leor J. The origin of human mesenchymal stromal cells dictates their reparative properties. J Am Heart Assoc 2013, 2.
62. Nahrendorf M., Swirski F.K. Monocyte and macrophage heterogeneity in the heart. Circ. Res. 2013, 112:1624-1633.
63. Nahrendorf M., Swirski F.K., Aikawa E., Stangenberg L., Wurdinger T., Figueiredo J.L., Libby P., Weissleder R., Pittet M.J. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007, 204:3037-3047.
64. Nemeth K., Leelahavanichkul A., Yuen P.S., Mayer B., Parmelee A., Doi K., Robey P.G., Leelahavanichkul K., Koller B.H., Brown J.M., Hu X., Jelinek I., Star R.A., Mezey E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 2009, 15:42-49.
65. O'meara C.C., Wamstad J.A., Gladstone R.A., Fomovsky G.M., Butty V.L., Shrikumar A., Gannon J.B., Boyer L.A., Lee R.T. Transcriptional reversion of cardiac myocyte fate during mammalian cardiac regeneration. Circ. Res. 2015, 116:804-815.
66. Ong S.G., Huber B.C., Hee LEE W., Kodo K., Ebert A.D., MA Y., Nguyen P.K., Diecke S., Chen W.Y., WU J.C. Microfluidic single-cell analysis of transplanted human induced pluripotent stem cell-derived cardiomyocytes after acute myocardial infarction. Circulation 2015, 132:762-771.
67. Oskouei B.N., Lamirault G., Joseph C., Treuer A.V., Landa S., Da Silva J., Hatzistergos K., Dauer M., Balkan W., Mcniece I., Hare J.M. Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair. Stem Cells Transl. Med. 2012, 1:116-124.
68. Perin E.C., Sanz-Ruiz R., Sanchez P.L., Lasso J., Perez-Cano R., Alonso-Farto J.C., Perez-David E., Fernandez-Santos M.E., Serruys P.W., Duckers H.J., Kastrup J., Chamuleau S., Zheng Y., Silva G.V., Willerson J.T., Fernandez-Aviles F. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: the PRECISE trial. Am. Heart J. 2014, 168(88-95).
69. Plaks V., Boldajipour B., Linnemann J.R., Nguyen N.H., Kersten K., Wolf Y., Casbon A.J., Kong N., Van Den Bijgaart R.J., Sheppard D., Melton A.C., Krummel M.F., Werb Z. Adaptive immune regulation of mammary postnatal organogenesis. Dev. Cell 2015, 34:493-504.
70. Planat-Benard V., Silvestre J.S., Cousin B., Andre M., Nibbelink M., Tamarat R., Clergue M., Manneville C., Saillan-Barreau C., Duriez M., Tedgui A., Levy B., Penicaud L., Casteilla L. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004, 109:656-663.
71. Puceat M. Could a pluripotent stem cell give rise to a high yield of a single cell lineage: a myocardial cell?. Curr. Opin. Genet. Dev. 2013, 23:498-499.
72. Ratajczak M.Z., Machalinski B., Wojakowski W., Ratajczak J., Kucia M. A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in adult bone marrow and other tissues. Leukemia 2007, 21:860-867.
73. Richart A., Loyer X., Neri T., Howangyin K., Guerin C.L., Ngkelo A., Bakker W., Zlatanova I., Rouanet M., Vilar J., Levy B., Rothenberg M., Mallat Z., Puceat M., Silvestre J.S. MicroRNA-21 coordinates human multipotent cardiovascular progenitors therapeutic potential. Stem Cells 2014, 32:2908-2922.
74. Riegler J., Tiburcy M., Ebert A., Tzatzalos E., Raaz U., Abilez O.J., Shen Q., Kooreman N.G., Neofytou E., Chen V.C., Wang M., Meyer T., Tsao P.S., Connolly A.J., Couture L.A., Gold J.D., Zimmermann W.H., Wu J.C. Human engineered heart muscles engraft and survive long term in a rodent myocardial infarction model. Circ. Res. 2015, 117:720-730.
75. Roncalli J., Mouquet F., Piot C., Trochu J.N., Le Corvoisier P., Neuder Y., Le Tourneau T., Agostini D., Gaxotte V., Sportouch C., Galinier M., Crochet D., Teiger E., Richard M.J., Polge A.S., Beregi J.P., Manrique A., Carrie D., Susen S., Klein B., Parini A., Lamirault G., Croisille P., Rouard H., Bourin P., Nguyen J.M., Delasalle B., Vanzetto G., Van Belle E., Lemarchand P. Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. Eur. Heart J. 2011, 32:1748-1757.
76. Rossini A., Frati C., Lagrasta C., Graiani G., Scopece A., Cavalli S., Musso E., Baccarin M., Di Segni M., Fagnoni F., Germani A., Quaini E., Mayr M., Xu Q., Barbuti A., Difrancesco D., Pompilio G., Quaini F., Gaetano C., Capogrossi M.C. Human cardiac and bone marrow stromal cells exhibit distinctive properties related to their origin. Cardiovasc. Res. 2011, 89:650-660.
77. Sahara M., Santoro F., Chien K.R. Programming and reprogramming a human heart cell. EMBO J 2015, 34:710-738.
78. Sanchez-Freire V., Lee A.S., Hu S., Abilez O.J., Liang P., Lan F., Huber B.C., Ong S.G., Hong W.X., Huang M., WU J.C. Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells. J. Am. Coll. Cardiol. 2014, 64:436-448.
79. Seeger F.H., Rasper T., Fischer A., Muhly-Reinholz M., Hergenreider E., Leistner D.M., Sommer K., Manavski Y., Henschler R., Chavakis E., Assmus B., Zeiher A.M., Dimmeler S. Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair. Circ. Res. 2012, 111:854-862.
80. Seeger F.H., Tonn T., Krzossok N., Zeiher A.M., Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur. Heart J. 2007, 28:766-772.
81. Seeger F.H., Zeiher A.M., Dimmeler S. MicroRNAs in stem cell function and regenerative therapy of the heart. Arterioscler. Thromb. Vasc. Biol. 2013, 33:1739-1746.
82. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012, 122:787-795.
83. Silvestre J.S., Smadja D.M., Levy B.I. Postischemic revascularization: from cellular and molecular mechanisms to clinical applications. Physiol. Rev. 2013, 93:1743-1802.
84. Tse H.F., Siu C.W., Zhu S.G., Songyan L., Zhang Q.Y., Lai W.H., Kwong Y.L., Nicholls J., Lau C.P. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur. J. Heart Fail. 2007, 9:747-753.
85. Tseliou E., Fouad J., Reich H., Slipczuk L., De Couto G., Aminzadeh M., Middleton R., Valle J., Weixin L., Marban E. Fibroblasts rendered antifibrotic, antiapoptotic, and angiogenic by priming with cardiosphere-derived extracellular membrane vesicles. J. Am. Coll. Cardiol. 2015, 66:599-611.
86. Wei K., Serpooshan V., Hurtado C., Diez-Cunado M., Zhao M., Maruyama S., Zhu W., Fajardo G., Noseda M., Nakamura K., Tian X., Liu Q., Wang A., Matsuura Y., Bushway P., Cai W., Savchenko A., Mahmoudi M., Schneider M.D., Van Den Hoff M.J., Butte M.J., Yang P.C., Walsh K., Zhou B., Bernstein D., Mercola M., Ruiz-Lozano P. Epicardial FSTL1 Reconstitution Regenerates the Adult Mammalian Heart. Nature 2015.
87. Werner G.S., Richartz B.M., Gastmann O., Ferrari M., Figulla H.R. Immediate changes of collateral function after successful recanalization of chronic total coronary occlusions. Circulation 2000, 102:2959-2965.
88. Yeghiazarians Y., Zhang Y., Prasad M., Shih H., Saini S.A., Takagawa J., Sievers R.E., Wong M.L., Kapasi N.K., Mirsky R., Koskenvuo J., Minasi P., YE J., Viswanathan M.N., Angeli F.S., Boyle A.J., Springer M.L., Grossman W. Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy. Mol. Ther. 2009, 17:1250-1256.
89. You D., Cochain C., Loinard C., Vilar J., Mees B., Duriez M., Levy B.I., Silvestre J.S. Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents. Hypertension 2008, 51:1537-1544.
90. Yuan A., Farber E.L., Rapoport A.L., Tejada D., Deniskin R., Akhmedov N.B., Farber D.B. Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One 2009, 4.
91. Zaruba M.M., Soonpaa M., Reuter S., Field L.J. Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation 2010, 121:1992-2000.
92. Zheng S.X., Weng Y.L., Zhou C.Q., Wen Z.Z., Huang H., Wu W., Wang J.F., Wang T. Comparison of cardiac stem cells and mesenchymal stem cells transplantation on the cardiac electrophysiology in rats with myocardial infarction. Stem Cell Rev. 2013, 9:339-349.
93. Zouggari Y., Ait-Oufella H., Bonnin P., Simon T., Sage A.P., Guerin C., Vilar J., Caligiuri G., Tsiantoulas D., Laurans L., Dumeau E., Kotti S., Bruneval P., Charo I.F., Binder C.J., Danchin N., Tedgui A., Tedder T.F., Silvestre J.S., Mallat Z. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat. Med. 2013, 19:1273-1280.